Traditional Versus Progressive Robot-assisted Gait Training in People With Multiple Sclerosis and Severe Gait Disability - Trial NCT06381440
Access comprehensive clinical trial information for NCT06381440 through Pure Global AI's free database. This phase not specified trial is sponsored by University Hospital of Ferrara and is currently Recruiting. The study focuses on Multiple Sclerosis. Target enrollment is 24 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University Hospital of Ferrara
Timeline & Enrollment
N/A
Nov 15, 2023
Nov 30, 2024
Primary Outcome
Walking function
Summary
Multiple sclerosis (MS) is a demyelinating neurodegenerative disease. Qualitative alterations
 in walking function in MS people involve 75% of subjects with MS and are determined by
 reduced coordination, mobility, balance, and increased risk of falling. Robot assisted gait
 training (RAGT) devices seem effective in MS patients with severe motor disabilities, failing
 to show significant superiority when compared to intensive overground gait rehabilitation
 (OGT). This study aims to evaluate the effects of a low-intensity RAGT at progressively
 increasing intensity compared to conventional RAGT and OGT.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06381440
Device Trial